PDF herunterladen
Thromb Haemost 1992; 68(02): 230-231
DOI: 10.1055/s-0038-1656354
Letter to the Editor
Schattauer GmbH Stuttgart

Lack of Correction of Acquired Heparin Cofactor II Deficiency in Patients with Liver Failure after Successful Orthotopic Liver Transplantation

P Toulon
1   Laboratoire d'Hématologie, Hôpital Cochin, 27 rue du Fbg Saint-Jacques, F-75674 Paris Cedex 14, France
,
I Ledjev
1   Laboratoire d'Hématologie, Hôpital Cochin, 27 rue du Fbg Saint-Jacques, F-75674 Paris Cedex 14, France
,
Y Ozier
2   Departement d'Anesthésie, Hôpital Cochin, 27 rue du Fbg Saint-Jacques, F-75674 Paris Cedex 14, France
,
J F Garnier
2   Departement d'Anesthésie, Hôpital Cochin, 27 rue du Fbg Saint-Jacques, F-75674 Paris Cedex 14, France
,
D Houssin
3   Clinique Chirurgicale, Hôpital Cochin, 27 rue du Fbg Saint-Jacques, F-75674 Paris Cedex 14, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 03. Februar 1992

Accepted 26. Februar 1992

Publikationsdatum:
03. Juli 2018 (online)

  als PDF herunterladen  Lizenzen und Reprints
 

  • References

  • 1 Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989; 321: 1014-1022
    CrossrefPubMedGoogle Scholar
  • 2 Tollefsen DM, Blank MK. Detection of a new heparin-dependent inhibitor of thrombin in human plasma. J Clin Invest 1981; 68: 589-596
    CrossrefPubMedGoogle Scholar
  • 3 Griffith MJ, Noyes CM, Church FC. Reactive site peptide similarity between heparin cofactor II and antithrombin III. J Biol Chem 1985; 260: 2218-2225
    PubMedGoogle Scholar
  • 4 Tollefsen DM, Pestka CA. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure. Blood 1985; 66: 769-774
    PubMedGoogle Scholar
  • 5 Jaffe EA, Armellino D, Tollefsen DM. Biosynthesis of functionally active heparin cofactor II by a hepatoma-derived cell line. Biochem Biophys Res Commun 1985; 132: 368-374
    CrossrefPubMedGoogle Scholar
  • 6 Toulon P, Bardin JM, Blumenfeld N. Increased heparin cofactor II levels in women taking oral contraceptives. Thromb Haemostas 1991; 64: 365-368
    PubMedGoogle Scholar
  • 7 Toulon P, Costa JM, Amiral J. An enzyme-linked immunosorbent assay (ELISA) for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materials. Clin Chim Acta 1992; 205: 65-73
    PubMedGoogle Scholar
  • 8 Kobayashi N, Takeda Y. Studies of the effects of estradiol, progesterone, cortisol, thrombophlebitis, and typhoid vaccine on synthesis and catabolism of antithrombin III in the dog. Thromb Haemostas 1977; 37: 111-122
    PubMedGoogle Scholar
  • 9 Toulon P, Moulonguet-Doleris L, Costa JM, Aiach M. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis. Thromb Haemostas 1991; 65: 20-24
    PubMedGoogle Scholar
  • 10 Tsakis AG, Gordon RD, Shaw BW, Iwatsuki S, Starzl TE. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation 1985; 40: 667-671
    CrossrefPubMedGoogle Scholar